![]() |
CrossRef Text and Data Mining |
Result of CrossRef Text and Data Mining Search is the related articles with entitled article. If you click link1 or link2 you will be able to reach the full text site of selected articles; however, some links do not show the full text immediately at now. If you click CrossRef Text and Data Mining Download icon, you will be able to get whole list of articles from literature included in CrossRef Text and Data Mining. |
Promising treatment results of adjuvant chemotherapy following radical hysterectomy for intermediate risk stage 1B cervical cancer |
Tae Yeon Lee, Yi Jo Jeung, Chun Jun Lee, Heung Yeol Kim, Sung Han Kim, Won Gyu Kim |
Obstet Gynecol Sci. 2013;56(1):15-21. Published online January 9, 2013 DOI: https://doi.org/10.5468/OGS.2013.56.1.15 |
Promising treatment results of adjuvant chemotherapy following radical hysterectomy for intermediate risk stage 1B cervical cancer Treatment Results of Adjuvant Chemotherapy after Radical Hysterectomy for Intermediate-Risk Stage IB-IIB Cervical Cancer Treatment results of adjuvant chemotherapy after radical hysterectomy for intermediate- and high-risk stage IB–IIA cervical cancer Mitomycin C adjuvant chemotherapy after Wertheim's hysterectomy for stage IB cervical cancer A randomized trial of adjuvant chemotherapy after radical hysterectomy in stage Ib-IIa cervical cancer patients with pelvic lymph node metastases☆ Radical hysterectomy followed by tailored postoperative therapy in the treatment of stage IB2 cervical cancer: feasibility and indications for adjuvant therapy Postoperative adjuvant chemotherapy combined with intracavitary brachytherapy in early-stage cervical cancer patients with intermediate risk factors Vaginal Radical Hysterectomy versus Abdominal Radical Hysterectomy in the Treatment of Early-Stage Cervical Cancer Robotic radical hysterectomy following neoadjuvant chemotherapy in FIGO stage IIIB cervical cancer: a case report Oncologic outcomes of adjuvant chemotherapy in patients with risk factors after radical surgery in FIGO stage IB–IIA cervical cancer |